Skip to content
Menu

Piper Sandler Initiates Coverage On Innoviva with Overweight Rating, Announces Price Target of $29

Benzinga Newsdesk 13 hours ago

Analyst RatingsNewsInitiationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Piper Sandler analyst David Amsellem initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $29.

Piper Sandler analyst David Amsellem initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $29.

Read at benzinga.com